The strengths of this study include its novel insights into the molecular mechanisms by which GTSE1 accelerates HCC progression and its inclusion of the 10-year follow up on the effect of GTSE1 on HCC survival. The gene discussed is GTSE1; the disease is hepatocellular carcinoma.